DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slid 5.83% to $35.54 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.10% to 15,712.75 and the Dow Jones Industrial Average falling 0.11% to 38,460.92.
Corbus Pharmaceuticals Holdings Inc. closed $14.33 short of its 52-week high ($49.87), which the company achieved on March 13th.
The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 1.51% to $4.56, Fortress Biotech Inc. (FBIO) fell 1.10% to $1.79, and Viking Therapeutics Inc. $(VKTX)$ rose 0.22% to $65.07.
Trading volume (220,992) remained 81,983 below its 50-day average volume of 302,975.
Data source: Dow Jones Market Data, FactSet. Data compiled April 24, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 24, 2024 17:27 ET (21:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments